# Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

> **NCT00754143** · PHASE1 · COMPLETED · sponsor: **Kyntra Bio** · enrollment: 38 (actual)

## Conditions studied

- Diabetes Mellitus
- Diabetic Nephropathy

## Interventions

- **DRUG:** FG-3019
- **DRUG:** FG-3019
- **DRUG:** FG-3019

## Key facts

- **NCT ID:** NCT00754143
- **Lead sponsor:** Kyntra Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754143, "Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00754143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*